Montelukast Prescribing at THE CRESCENT MEDICAL CTR.
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
805
Total Quantity
20.4K
NHS Cost
£983
vs National Avg
+17.6%
THE CRESCENT MEDICAL CTR. prescribed 805 items of Montelukast over the last 12 months at a cost of £983 to the NHS. This is 17.6% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
62
Jul 2026
79
Jul 2026
71
Jul 2026
66
Jul 2026
64
Jul 2026
67
Jul 2026
81
Jul 2026
68
Jul 2026
63
Jul 2026
54
Jul 2026
68
Jul 2026
62
Prescribing Details
| Total Items | 805 |
|---|---|
| Total Quantity | 20,414 |
| Total NHS Cost | £983 |
| Presentations | 3 different forms |
| vs National Average | +17.6% |
Montelukast Prescribing Comparison
| This practice | 805 items |
|---|---|
| National average per practice | 685 items |
| Difference | +17.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.